Stock APLM APOLLOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Apollomics, Inc.

Equities

APLM

KYG0411D1079

Market Closed - Nasdaq
Other stock markets
 21:30:00 24/06/2024 BST 		5-day change 1st Jan Change
0.22 USD +7.53% Intraday chart for Apollomics, Inc. +14.88% -77.20%
06-04 Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting CI
05-08 Apollomics, Inc. Appoints Robert Lin to the Board of Directors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APOLLOMICS, INC. Stock Apollomics, Inc.
 24.14M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 115B
ARGENX SE Stock argenx SE
 25.85B -
BIONTECH SE Stock BioNTech SE
 20.9B -
GENMAB A/S Stock Genmab A/S
 16.52B
  1. Stock Market
  2. Equities
  3. APLM Stock
  4. Charts Apollomics, Inc.
  5. Sector Chart